Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in pH, size of inoculum, addition of human serum, and repeated exposure to subinhibitory levels of antibiotics. We tested for synergism of these drugs with cefoxitin against...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174790/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3606066/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.619 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|